Development of cell assays for exploration of novel immunotherapeutic drugs for cancer treatment
Bladder cancer remains a prevalent and deadly cancer form worldwide. While immunotherapy has yielded significant progress, additional therapeutic strategies are needed to improve the response in bladder cancer patients. A novel immune cell target, referred to as “protein X”, has previously been identified in Lundberg’s lab. Antibodies developed against protein X were provided to us, with the aim o
